Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Gastrointestinal carcinoid tumor
Results 1-25 of 28 for your search:
Start Over
Embolization Therapy with or without Chemotherapy in Controlling Liver Metastases in Patients with Neuroendocrine Tumor Metastases to the Liver That Cannot Be Removed by Surgery
Status: Active
Phase: Phase III
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC01215, NCI-2016-00610, NCT02724540
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Pazopanib Hydrochloride in Treating Patients with Progressive Carcinoid Tumors
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A021202, NCI-2013-00831, ALLIANCE A021202, CALGB-A021202, NCT01841736
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients with Primary or Metastatic Gastrointestinal or Pancreatic Neuroendocrine Tumors
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 13-C-0193, NCI-2014-02318, 335154, NCT01967537
Regorafenib in Treating Patients with Advanced or Metastatic Neuroendocrine Tumors
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0S-14-3, NCI-2014-01996, HS-14-00583, NCT02259725
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling by invitation
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: OX4219s, NCI-2015-00120, NCT02279602
Mutation-Targeted Therapy with Sunitinib Malate or Everolimus in Treating Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal Tract or Pancreas
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 15-C-0040, NCI-2015-00091, 339636, P141605, 150040, NCT02315625
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients with Somatostatin-Receptor Positive Tumors
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 19 and over
Trial IDs: NET0017, NCI-2014-01016, 26988, NCI-2014-00101, NCT01980732
Alisertib and Combination Chemotherapy in Treating Patients with Gastrointestinal Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9824, NCI-2014-02475, VICC GI1536, NCT02319018
Ropidoxuridine in Treating Patients with Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9882, NCI-2015-00258, BRUOG 265, NCT02381561
Liposomal Irinotecan and Veliparib in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9914, NCI-2015-02125, TBD, NCT02631733
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients with Metastatic Gastrointestinal Tumors
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0152, NCI-2016-01058, NCT02757391
Long-Term Follow up for Patients Previously Enrolled in National Cancer Institute Surgery Branch Studies
Status: Enrolling by invitation
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 16 and over
Trial IDs: 09-C-0161, NCI-2015-01184, 344944, P09518, 090161, 304795, NCT00923026
Molecular Analysis of Tissue Samples from Patients with Endocrine Neoplasms
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 7 and over
Trial IDs: 09-C-0242, NCI-2015-01205, P09555, NCT01005654
Collection of Tissue Samples in Identifying Novel Therapeutic Targets in Patients with Solid Tumors Undergoing Surgery or Biopsy
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Age: 16 and over
Trial IDs: 12-C-0175, NCI-2015-01248, 320831, P121006, NCT01658917
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 18 and over
Trial IDs: CGI-061, NCI-2013-01950, NCT02092714
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Status: Active
Phase: No phase specified
Type: Health services research, Supportive care
Age: 18 to 39
Trial IDs: 9161, NCI-2014-01325, NCT02192333
Massage Therapy in Reducing Oxaliplatin-Induced Peripheral Neuropathy in Patients with Gastrointestinal or Breast Malignancies
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 2014-0250, NCI-2015-00386, NCT02221700
18F-MFBG PET/CT in Imaging Patients with Neuroendocrine Malignancies
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 5 and over
Trial IDs: 14-138, NCI-2015-00234, NCT02348749
Gallium Ga 68-edotreotide PET/CT in Diagnosing Patients with Neuroendocrine Tumors
Status: Enrolling by invitation
Phase: No phase specified
Type: Diagnostic
Age: Not specified
Trial IDs: 14-226, NCI-2015-00286, NCT02358018
Online Coping Skills Curriculum in Improving Quality of Life in Cancer Patients and Survivors with Chronic Pain
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00061381, NCI-2015-00756, NCT02465892
Assessing Quality of Life in Patients with Refractory Malignant Ascites Undergoing Peritoneal-Venous Shunt
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: UPCC 26813, NCI-2015-01009, 819053, NCT02477657
Start Over